Monotherapy with GI262570, a non-thiazolidinedione PPARγ agonist, improves glycemic control in type 2 diabetes mellitus patients (T2DM)

被引：0

作者：

Abou-Donia, M

Fiedorek, FT

Wilson, GG

Frith, L

Patel, J

机构：

[1] Glaxo Wellcome Co, Res Triangle Pk, NC USA

[2] PPA20005 Study Grp, Greenford, Middx, England

来源：

DIABETOLOGIA | 2000年 / 43卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

726

引用

页码：A189 / A189

页数：1

共 50 条

[21] Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
Kovacs, Christopher
Seshiah, Veeraswamy
Swallow, Ros
Jones, Russell
Rattunde, Henning
Woerle, Hans J.
Broedl, Uli C.
DIABETES, 2013, 62 : A291 - A291
[22] Retrospective study of type 2 diabetes mellitus (T2DM) patients not optimally controlled by metformin monotherapy
He, J.
Neslusan, C.
VALUE IN HEALTH, 2008, 11 (03) : A18 - A18
[23] Vildagliptin added to metformin improves glycemic control and may mitigate metformin-induced GI side effects in patients with type 2 diabetes (T2DM)
Garber, Alan
Camisasca, Riccardo P.
Ehrsam, Elena
Collober-Maugeais, Carole
Rochotte, Erika
Lebeaut, Alexandre
DIABETES, 2006, 55 : A29 - A29
[24] Twelve-week monotherapy with the DPP-4 inhibitor, LAF237 improves glycemic control in patients with type 2 diabetes (T2DM)
Pratley, R
Galbreath, E
DIABETES, 2004, 53 : A83 - A83
[25] Anti-hypertensive effect of farglitazar, a tyrosine-based non-thiazolidinedione PPARγ agonist, in patients with type 2 diabetes and hypertension
Home, PD
Piaditis, G
Koelendorf, K
Raz, I
Murphy, L
Smith, PL
Kler, L
Dave, J
Tandy, D
DIABETES, 2001, 50 : A117 - A117
[26] Alogliptin monotherapy improves glycemic control in patients with type 2 diabetes
Defronzo, Ralph
Fleck, Penny
Wilson, Craig
Mekki, Qais
DIABETES, 2008, 57 : A133 - A133
[27] Patterns of oral antihyperglycemic therapy and level of glycemic control among patients with Type 2 diabetes mellitus (T2DM) in Taiwan
Sheu, Wayne Huey-Herng
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S70 - S70
[28] Level of glycemic control and patterns of oral antihyperglycemic therapy among patients with Type 2 diabetes mellitus (T2DM) in Thailand
Nitiyanant, Wannee
Bunnag, Pongamorn
Suwanwalaikorn, Sompongse
Benjasuratwong, Yupin
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S70 - S70
[29] Personality, Self-Management Behaviors, and Glycemic Control among Japanese Patients with Type 2 Diabetes Mellitus (T2DM)
Morikawa, Sakiko Y.
Fujihara, Kazuya
Hatta, Mariko
Takeda, Yasunaga
Ishii, Dai
Yachida, Junko
Horikawa, Chika
Kato, Mitsutoshi
Maegawa, Hiroshi
Sone, Hirohito
DIABETES, 2019, 68
[30] Hyperglycemia Drives Glycemic Variability in Patients with Type 2 Diabetes (T2DM)
Olawsky, Evan A.
Zhang, Yuan
Alvear, Alison C.
Eberly, Lynn E.
Chow, Lisa S.
DIABETES, 2020, 69

← 1 2 3 4 5 →